During a shortage last year, the FDA allowed some compounding, but the shortage has resolved and the two drug manufacturers say such compounding violates their exclusive rights to their drugs
This weight loss program was full of educational information and it truly enabled me to address the root of my problems
Its wide-ranging benefits make it a leading option for individuals struggling with obesity or metabolic health issues
The review confirmed that GLP-1RAs consistently reduced energy intake and influenced reward-related behaviour across human studies
Paradoxically, fatigue is among the commonly reported adverse effects of GLP-1 therapy, particularly during the initial weeks of treatment or following dose escalation
Reviewing thyroid function, insulin sensitivity, and cortisol can identify a metabolic obstacle that the medication alone is not addressing